Study on the curative effect of Liangxue Heying Fang and Liangxue Huayu Fang in the treatment of cutaneous vasculitis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052797

Enrollment

Unknown

Registered

2021-11-05

Start date

2021-11-04

Completion date

Unknown

Last updated

2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous vasculitis

Interventions

Experimental group:Basic treatment + oral administration of Liangxue Heying Fang and Liangxue Huayu Fang Granules

Control group:Oral placebo on base therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for cutaneous vasculitis; 2. In line with the syndrome of dampness and heat in traditional Chinese medicine; 3. No age limit; 4. No gender limit; 5. Voluntarily join the clinical trial research and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Combining bleeding diseases, severe liver and kidney insufficiency, systemic infectious diseases, malignant tumors and mental diseases; 2. Severe allergic constitution; 3. Pregnant or lactating patients; 4. Those who are allergic to the test drug or its constituents.

Design outcomes

Primary

Measure	Time frame
TCM symptom score;Safety;Therapeutic effect;	—

Countries

China

Contacts

Public ContactCao Yemin

Shanghai Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

dr-cao@163.com+86 13361831119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026